Article
Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes.
Blood advances - 26 Jul 2022
Tsai Harrison K, Gibson Christopher J, Murdock H Moses, Davineni Phani, Harris Marian H, Wang Eunice S, Gondek Lukasz P, Kim Annette S, Nardi Valentina, Lindsley R Coleman
Abstract excerpt
KMT2A partial tandem duplication (KMT2A-PTD) is an adverse risk factor in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), a potential therapeutic target, and an attractive marker of measurable residual disease. High initial KMT2A-PTD RNA levels have been linked to poor prognosis, but mechanisms regulating KMT2A-PTD expression are not well understood. Although KMT2A-PTD has been reported to affect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
